Curapath
1 known investors
Find your way into Curapath
Sign up to find every way you can get introduced to Curapath
- Your email: who you already know at Curapath, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Curapath team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.
Founders & leadership
P
PhilippeChief Executive Officer
V
VicentChief Technology Officer
Investors · 1
Columbus Venture Partnerslisted by Columbus Venture PartnersValenciavia Jose Mesa · inferred
How we know: Columbus Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Curapath do?
- Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.
- Who are Curapath's investors?
- Curapath's investors include Columbus Venture Partners.
